FDA Clearance Tracker · P050038-S004
ARISTA AH ABSORBABLE HEMOSTAT
Last checked: Nov 20, 2026Latest source record: Jan 14, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Jan 14, 2008
Approved
Time to decision
59 days
Received Nov 16, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050038-S004
- Device name
- ARISTA AH ABSORBABLE HEMOSTAT
- Applicant
- Davol, Inc.
- Applicant location
- Warwick, RI
- Received
- Nov 16, 2007
- Decided
- Jan 14, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050038
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT ENPATH MEDICAL, INC., MINNEAPOLIS, MINNESOTA TO PERFORM FILLING, PACKAGING, AND LABELING OF THE DEVICE.
Source documents
Other decisions for Davol, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.